High blood pressure drug recall expands again over cancer risk

The FDA has advised consumers that Torrent Pharmaceuticals is voluntarily expanding its blood pressure medication recall over the presence of an impurity that may trigger the development of cancer in some patients. The expansion covers another two lots of Losartan Potassium / Hydrochlorothiazide tablets USP, as well as three lots of Losartan Potassium tablets USP. As with the original recall, …